Lunit and Agfa HealthCare Bring Breast Imaging AI Solution to Dubai Academic Health Corporation Dubai Hospital
Lunit INSIGHT MMG, Lunit's AI solution for mammography analysis
IMAGING
1 min.Read

Lunit and Agfa HealthCare Bring Breast Imaging AI Solution to Dubai Academic Health Corporation Dubai Hospital

Lunit (KRX:328130.KQ), in conjunction with Agfa HealthCare, today announced the successful ‘GO LIVE’ of the breast imaging AI solution, Breast AI Analysis Package, at Dubai Academic Health Corporation (DAHC) Dubai Hospital.

The Breast AI Analysis Package is a workflow-centric, evidence-based AI package part of Agfa’s RUBEE for AI framework, embedded in Agfa HealthCare’s Enterprise Imaging solution. Powered by Lunit INSIGHT MMG, the solution package helps improve radiologists’ screening and diagnostic workflow by providing advanced visualizations, workflow orchestration and triage benefits, dedicated reading protocols, and report notifications—thus helping early detection of breast cancer through cost-effective, quality diagnostic services.

Lunit INSIGHT MMG is one of Lunit’s most mature radiology products. The AI solution analyzes mammography images with high speed and 96% accuracy. By detecting suspicious lesions in mammography images, the AI solution helps radiologists distinguish suspected tumor areas by providing the location of the lesion with an abnormality score reflecting the AI’s confidence level.

The Breast AI Analysis Package is Lunit’s first application in Agfa HealthCare’s RUBEE for AI framework after the two company’s partnership agreement in 2021.

According to Data Bridge Market Research, the medical imaging market in the Middle East, which surpassed USD 20 billion in 2021, is projected to exceed USD 30 billion by 2029, with an expected CAGR of 5.5% from 2022 to 2029.[1]

Brandon Suh, CEO of Luni said:

“Since 2022, Lunit has continued to expand our business in the UAE and Middle Eastern market through partnerships with Roche and Microsoft Azure, and the Abu Dhabi Health Service Company (SEHA). We are thrilled to team with Agfa HealthCare to introduce our AI solution and help improve the delivery of patient care at DAHC.”

“The Breast AI Analysis package provides powerful tools for cancer risk-based triage, along with natively embedded CAD AI visualizations and advanced 2D/3D mammography tools powered by Lunit INSIGHT MMG,” said Dr. Anjum Ahmed, Global Chief Medical Officer and the Director of Artificial Intelligence Innovations at Agfa HealthCare.

[1] Middle East and Africa Medical Imaging Market – Industry Trends and Forecast to 2029, Data Bridge Market Research (2022.06)
SourceLunit

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

0
Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

0
Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

0
Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

0
The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

0
“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

About us

Medical Device News Magazine

Welcome to Medical Device News Magazine, a digital publication providing up to the minute medical device news and biotechnology news.

Need to know more?

Contact us

Navigation

Florida, New York
United States
Phone Number: 1.561.316.3330